More than 40% of FDA device center scientists responding to a recent survey believe that business interests are given too much consideration at the agency. Nevertheless, a strong majority felt that the agency is effectively protecting public health.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?